Bleeding changes after levonorgestrel 52mg intrauterine system insertion for contraception in women with self-reported heavy menstrual bleeding

Reproductive Health

Women's preferences for the levonorgestrel intrauterine system versus endometrial ablation for heavy menstrual bleeding

Eur J Obstet Gynecol Reprod Biol.

van den Brink MJ, Beelen P, Herman MC, Claassen NJJ, Bongers MY, Geomini PM, van der Steeg JW, van den Wijngaard L, van Wely M

doi: 10.1016/j.ejogrb.2018.06.020.

Reproductive Health

Menstrual bleeding and spotting with the Levonorgestrel Intrauterine System (52 mg) during the first-year post-insertion: a systematic review and meta-analysis

Am J Obstet Gynecol.

Maldonado LY, Sergison JE, Gao X, Hubacher D

doi: 10.1016/j.ajog.2019.09.044.

Reproductive Health

Levonorgestrel releasing intrauterine system versus endometrial ablation for heavy menstrual bleeding

Am J Obstet Gynecol.

Beelen P, VAN DEN Brink MJ, Herman MC, Geomini PM, Dekker JH, Duijnhoven RG, Nienke MAK, VAN Meurs HS, Coppus SF, VAN DER Steeg JW, Eising HP, Massop-Helmink DS, Klinkert ER, Nieboer TE, Timmermans A, VAN DER Voet LF, Veersema S, Smeets NAC, Schutte JM, VAN Baal M, Bossuyt PM, Mol BWJ, Berger MY, Bongers MY

doi: 10.1016/j.ajog.2020.08.016.

Reproductive Health

Endometrial ablation or resection versus levonorgestrel intra-uterine system for the treatment of women with heavy menstrual bleeding and a normal uterine cavity: a systematic review with meta-analysis

Hum Reprod Update.

Bergeron C, Laberge PY, Boutin A, Thériault MA, Valcourt F, Lemyre M, Maheux-Lacroix S

doi: 10.1093/humupd/dmz051.

Reproductive Health

Five-Year Contraceptive Efficacy and Safety of a Levonorgestrel 52-mg Intrauterine System

Obstet Gynecol.

Teal SB, Turok DK, Chen BA, Kimble T, Olariu AI, Creinin MD

doi: 10.1097/AOG.

Further Publications UrologyFurther Publications Gynecology

Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial

Obstet Gynecol.

Carr BR, Stewart EA, Archer DF, Al-Hendy A, Bradley L, Watts NB, Diamond MP, Gao J, Owens CD, Chwalisz K, Duan WR, Soliman AM, Dufek MB, Simon JA.

doi: 10.1097/AOG.

Reproductive Health

Levonorgestrel Intrauterine System associated amenorrhea: a systematic review and meta-analysis

Am J Obstet Gynecol.

Sergison JE, Maldonado LY, Gao X, Hubacher D

doi: 10.1016/j.ajog.2018.12.008.

Further Publications UrologyFurther Publications Gynecology

Predictors of Response for Elagolix with Add-back Therapy in Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids

Am J Obstet Gynecol.

Al-Hendy A, Bradley L, Owens CD, Wang H, Barnhart KT, Feinberg E, Schlaff WD, Puscheck EE, Wang A, Gillispie V, Hurtado S, Muneyyirci-Delale O, Archer DF, Carr BR, Simon JA, Stewart EA

doi: 10.1016/j.ajog.2020.07.032.

Overcoming barriers to levonorgestrel-releasing intrauterine system placement: an evaluation of placement of LNG-IUS 8 using the modified EvoInserter^® in a majority nulliparous population

Contraception.

Gemzell-Danielsson K, Apter D, Lukkari-Lax E, Roth K, Serrani M

doi: 10.1016/

Related content

Women's preferences for the levonorgestrel intrauterine system versus endometrial ablation for heavy menstrual bleeding

Menstrual bleeding and spotting with the Levonorgestrel Intrauterine System (52 mg) during the first-year post-insertion: a systematic review and meta-analysis

Levonorgestrel releasing intrauterine system versus endometrial ablation for heavy menstrual bleeding

Endometrial ablation or resection versus levonorgestrel intra-uterine system for the treatment of women with heavy menstrual bleeding and a normal uterine cavity: a systematic review with meta-analysis

Five-Year Contraceptive Efficacy and Safety of a Levonorgestrel 52-mg Intrauterine System

Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial

Levonorgestrel Intrauterine System associated amenorrhea: a systematic review and meta-analysis

Predictors of Response for Elagolix with Add-back Therapy in Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids

Overcoming barriers to levonorgestrel-releasing intrauterine system placement: an evaluation of placement of LNG-IUS 8 using the modified EvoInserter® in a majority nulliparous population

Overcoming barriers to levonorgestrel-releasing intrauterine system placement: an evaluation of placement of LNG-IUS 8 using the modified EvoInserter^® in a majority nulliparous population